Host cell surface glycoconjugates (glycolipids and glycoproteins) (Glycocalyx)

Host cell surface glycolipids and glycoproteins, collectively referred to as the glycocalyx, form a dense, carbohydrate-rich layer on the exterior of nearly all eukaryotic cells. These molecules are essential for maintaining cellular homeostasis, mediating vital processes such as cell-cell recognition, adhesion, and signal transduction through interactions with various endogenous ligands and receptors [1][2][4]. In the context of infectious diseases, they serve as critical primary attachment factors or entry receptors for a wide array of pathogens, including influenza viruses, coronaviruses, and certain bacteria, which exploit specific glycan motifs to facilitate cellular invasion [4][6]. In oncology, alterations in the expression and structure of these surface glycoconjugates, such as hypersialylation or increased glycan branching, are hallmark features that promote tumor metastasis, integrin clustering, and immune evasion [7][10]. Therapeutic strategies targeting these molecules typically involve the use of glycan mimetics, lectins, or monoclonal antibodies designed to block pathogen binding or modulate aberrant signaling in disease states [1][4]. However, because these molecules are ubiquitously expressed across diverse tissues, developing highly specific drugs remains a significant pharmacological challenge to avoid systemic toxicity and interference with normal physiological communication [7][8].

Other names

GlycocalyxCell surface glycansMembrane-bound glycoconjugatesSurface carbohydratesHost cell surface glycoconjugates

Inhibition of pathogen attachment and entry through glycan mimicry, competitive binding to carbohydrate-binding domains, or metabolic inhibition of glycan biosynthesis and processing.